Methods in Mouse Atherosclerosis

Cardiovascular disease is the major cause of death in most developed nations and the social and economic burden of this disease is quite high. Atherosclerosis is a major underlying basis for most cardiovascular diseases including myocardial infarction and stroke. Genetically modifi ed mouse models, particularly mice defi cient in apoprotein E or the LDL receptor, have been widely used in preclinical atherosclerosis studies to gain insight into the mechanisms underlying this pathology. This chapter reviews several mouse models of atherosclerosis progression and regression as well as the role of immune cells in disease progression and the genetics of murine atherogenesis.

[1]  M. McKee,et al.  Phosphate regulation of vascular smooth muscle cell calcification. , 2000, Circulation research.

[2]  Á. Millán,et al.  Role of calcium-phosphate deposition in vascular smooth muscle cell calcification. , 2011, American journal of physiology. Cell physiology.

[3]  R. Terkeltaub,et al.  Genetics in Arterial Calcification: Pieces of a Puzzle and Cogs in a Wheel , 2011, Circulation research.

[4]  R. Villa-Bellosta,et al.  Phosphonoformic Acid Prevents Vascular Smooth Muscle Cell Calcification by Inhibiting Calcium-Phosphate Deposition , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[5]  R. Aebersold,et al.  Smooth Muscle Cell Phenotypic Transition Associated With Calcification: Upregulation of Cbfa1 and Downregulation of Smooth Muscle Lineage Markers , 2001, Circulation research.

[6]  Dr. J. G. Mönckeberg.  Über die reine Mediaverkalkung der Extremitätenarterien und ihr Verhalten zur Arteriosklerose , 2005, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.

[7]  K. Watson,et al.  Bone morphogenetic protein expression in human atherosclerotic lesions. , 1993, The Journal of clinical investigation.

[8]  C. López-Otín,et al.  Defective Extracellular Pyrophosphate Metabolism Promotes Vascular Calcification in a Mouse Model of Hutchinson-Gilford Progeria Syndrome That Is Ameliorated on Pyrophosphate Treatment , 2013, Circulation.

[9]  G. London,et al.  Atherosclerosis and arteriosclerosis in chronic renal failure. , 1997, Kidney international.

[10]  L. Ibels,et al.  Role of phosphate and pyrophosphate in soft tissue calcification. , 1978, Advances in experimental medicine and biology.

[11]  P. Weissberg,et al.  High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[12]  F. Parhami,et al.  Monocyte/Macrophage Regulation of Vascular Calcification In Vitro , 2002, Circulation.

[13]  J. Skepper,et al.  Apoptosis Regulates Human Vascular Calcification In Vitro: Evidence for Initiation of Vascular Calcification by Apoptotic Bodies , 2000, Circulation research.

[14]  F. Port,et al.  Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  Alexandra E. Ewence,et al.  Calcium Phosphate Crystals Induce Cell Death in Human Vascular Smooth Muscle Cells: A Potential Mechanism in Atherosclerotic Plaque Destabilization , 2008, Circulation research.

[16]  S. Schwartz,et al.  Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). , 1991, Biochemical and biophysical research communications.